AwesomeCapital
Thursday, February 27, 2020
Concert Pharma EPS misses by $0.07
Concert Pharma (NASDAQ:
CNCE
): Q4 GAAP EPS of -$0.86
misses by $0.07
.
Revenue of $0.01M (flat Y/Y)
Press Release
https://seekingalpha.com/news/3546349-concert-pharma-eps-misses-0_07
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.